GO:0001607 | neuromedin U receptor activity | 1.02e-03 | 1.00e+00 | 9.931 | 1 | 1 | 1 |
GO:0042924 | neuromedin U binding | 1.02e-03 | 1.00e+00 | 9.931 | 1 | 1 | 1 |
GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling | 2.05e-03 | 1.00e+00 | 8.931 | 1 | 1 | 2 |
GO:0002023 | reduction of food intake in response to dietary excess | 2.05e-03 | 1.00e+00 | 8.931 | 1 | 1 | 2 |
GO:0033503 | HULC complex | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 1 | 4 |
GO:0005229 | intracellular calcium activated chloride channel activity | 5.11e-03 | 1.00e+00 | 7.610 | 1 | 1 | 5 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 5.11e-03 | 1.00e+00 | 7.610 | 1 | 1 | 5 |
GO:0043005 | neuron projection | 5.62e-03 | 1.00e+00 | 4.111 | 2 | 6 | 113 |
GO:0050847 | progesterone receptor signaling pathway | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 2 | 6 |
GO:0048016 | inositol phosphate-mediated signaling | 7.15e-03 | 1.00e+00 | 7.124 | 1 | 1 | 7 |
GO:0033523 | histone H2B ubiquitination | 7.15e-03 | 1.00e+00 | 7.124 | 1 | 1 | 7 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 1 | 8 |
GO:0008088 | axon cargo transport | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 1 | 8 |
GO:0010388 | cullin deneddylation | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 4 | 8 |
GO:0006940 | regulation of smooth muscle contraction | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 1 | 8 |
GO:0050482 | arachidonic acid secretion | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 1 | 8 |
GO:0010390 | histone monoubiquitination | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 2 | 8 |
GO:0007625 | grooming behavior | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 9 |
GO:0071354 | cellular response to interleukin-6 | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 9 |
GO:0035253 | ciliary rootlet | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 9 |
GO:0016874 | ligase activity | 9.24e-03 | 1.00e+00 | 3.742 | 2 | 11 | 146 |
GO:0005095 | GTPase inhibitor activity | 1.02e-02 | 1.00e+00 | 6.610 | 1 | 1 | 10 |
GO:0035307 | positive regulation of protein dephosphorylation | 1.02e-02 | 1.00e+00 | 6.610 | 1 | 1 | 10 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 1.12e-02 | 1.00e+00 | 6.472 | 1 | 4 | 11 |
GO:0017075 | syntaxin-1 binding | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 1 | 13 |
GO:0004842 | ubiquitin-protein transferase activity | 1.37e-02 | 1.00e+00 | 3.448 | 2 | 17 | 179 |
GO:0016575 | histone deacetylation | 1.43e-02 | 1.00e+00 | 6.124 | 1 | 2 | 14 |
GO:0031514 | motile cilium | 1.43e-02 | 1.00e+00 | 6.124 | 1 | 1 | 14 |
GO:0000188 | inactivation of MAPK activity | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 1 | 15 |
GO:0048265 | response to pain | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 1 | 16 |
GO:0005525 | GTP binding | 1.64e-02 | 1.00e+00 | 3.309 | 2 | 12 | 197 |
GO:0007631 | feeding behavior | 1.73e-02 | 1.00e+00 | 5.844 | 1 | 1 | 17 |
GO:0006378 | mRNA polyadenylation | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 3 | 18 |
GO:0071897 | DNA biosynthetic process | 2.03e-02 | 1.00e+00 | 5.610 | 1 | 2 | 20 |
GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 1 | 21 |
GO:0019894 | kinesin binding | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 1 | 21 |
GO:0019722 | calcium-mediated signaling | 2.23e-02 | 1.00e+00 | 5.472 | 1 | 1 | 22 |
GO:0031424 | keratinization | 2.33e-02 | 1.00e+00 | 5.408 | 1 | 2 | 23 |
GO:0006821 | chloride transport | 2.33e-02 | 1.00e+00 | 5.408 | 1 | 2 | 23 |
GO:0008180 | COP9 signalosome | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 6 | 24 |
GO:0005737 | cytoplasm | 2.85e-02 | 1.00e+00 | 1.154 | 6 | 127 | 2633 |
GO:0045786 | negative regulation of cell cycle | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 3 | 30 |
GO:0005871 | kinesin complex | 3.13e-02 | 1.00e+00 | 4.977 | 1 | 3 | 31 |
GO:0007254 | JNK cascade | 3.43e-02 | 1.00e+00 | 4.844 | 1 | 1 | 34 |
GO:0012505 | endomembrane system | 3.43e-02 | 1.00e+00 | 4.844 | 1 | 2 | 34 |
GO:1902476 | chloride transmembrane transport | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 2 | 36 |
GO:0003777 | microtubule motor activity | 3.92e-02 | 1.00e+00 | 4.646 | 1 | 3 | 39 |
GO:0000151 | ubiquitin ligase complex | 4.81e-02 | 1.00e+00 | 4.347 | 1 | 4 | 48 |
GO:0007218 | neuropeptide signaling pathway | 5.30e-02 | 1.00e+00 | 4.204 | 1 | 2 | 53 |
GO:0006816 | calcium ion transport | 5.30e-02 | 1.00e+00 | 4.204 | 1 | 1 | 53 |
GO:0042826 | histone deacetylase binding | 5.79e-02 | 1.00e+00 | 4.073 | 1 | 5 | 58 |
GO:0007417 | central nervous system development | 6.27e-02 | 1.00e+00 | 3.954 | 1 | 2 | 63 |
GO:0005923 | tight junction | 6.37e-02 | 1.00e+00 | 3.931 | 1 | 2 | 64 |
GO:0007204 | positive regulation of cytosolic calcium ion concentration | 6.37e-02 | 1.00e+00 | 3.931 | 1 | 1 | 64 |
GO:0030308 | negative regulation of cell growth | 6.94e-02 | 1.00e+00 | 3.802 | 1 | 3 | 70 |
GO:0001649 | osteoblast differentiation | 7.33e-02 | 1.00e+00 | 3.722 | 1 | 5 | 74 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 9.04e-02 | 1.00e+00 | 3.408 | 1 | 6 | 92 |
GO:0000209 | protein polyubiquitination | 9.04e-02 | 1.00e+00 | 3.408 | 1 | 6 | 92 |
GO:0008017 | microtubule binding | 9.51e-02 | 1.00e+00 | 3.332 | 1 | 9 | 97 |
GO:0042981 | regulation of apoptotic process | 1.09e-01 | 1.00e+00 | 3.124 | 1 | 4 | 112 |
GO:0007049 | cell cycle | 1.12e-01 | 1.00e+00 | 3.086 | 1 | 8 | 115 |
GO:0016020 | membrane | 1.16e-01 | 1.00e+00 | 1.279 | 3 | 56 | 1207 |
GO:0004930 | G-protein coupled receptor activity | 1.20e-01 | 1.00e+00 | 2.977 | 1 | 2 | 124 |
GO:0032403 | protein complex binding | 1.25e-01 | 1.00e+00 | 2.909 | 1 | 5 | 130 |
GO:0007165 | signal transduction | 1.28e-01 | 1.00e+00 | 1.660 | 2 | 24 | 618 |
GO:0031625 | ubiquitin protein ligase binding | 1.33e-01 | 1.00e+00 | 2.823 | 1 | 7 | 138 |
GO:0044212 | transcription regulatory region DNA binding | 1.37e-01 | 1.00e+00 | 2.772 | 1 | 13 | 143 |
GO:0007267 | cell-cell signaling | 1.42e-01 | 1.00e+00 | 2.722 | 1 | 1 | 148 |
GO:0005739 | mitochondrion | 1.43e-01 | 1.00e+00 | 1.567 | 2 | 32 | 659 |
GO:0005874 | microtubule | 1.55e-01 | 1.00e+00 | 2.583 | 1 | 10 | 163 |
GO:0008270 | zinc ion binding | 1.68e-01 | 1.00e+00 | 1.426 | 2 | 39 | 727 |
GO:0008152 | metabolic process | 1.72e-01 | 1.00e+00 | 2.424 | 1 | 6 | 182 |
GO:0005856 | cytoskeleton | 1.78e-01 | 1.00e+00 | 2.362 | 1 | 8 | 190 |
GO:0005743 | mitochondrial inner membrane | 1.84e-01 | 1.00e+00 | 2.309 | 1 | 9 | 197 |
GO:0019899 | enzyme binding | 1.95e-01 | 1.00e+00 | 2.217 | 1 | 7 | 210 |
GO:0005654 | nucleoplasm | 2.24e-01 | 1.00e+00 | 1.157 | 2 | 68 | 876 |
GO:0007155 | cell adhesion | 2.24e-01 | 1.00e+00 | 2.001 | 1 | 8 | 244 |
GO:0008285 | negative regulation of cell proliferation | 2.50e-01 | 1.00e+00 | 1.818 | 1 | 11 | 277 |
GO:0045892 | negative regulation of transcription, DNA-templated | 2.81e-01 | 1.00e+00 | 1.623 | 1 | 17 | 317 |
GO:0045893 | positive regulation of transcription, DNA-templated | 3.26e-01 | 1.00e+00 | 1.373 | 1 | 21 | 377 |
GO:0042803 | protein homodimerization activity | 3.61e-01 | 1.00e+00 | 1.190 | 1 | 13 | 428 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 3.80e-01 | 1.00e+00 | 1.099 | 1 | 29 | 456 |
GO:0005515 | protein binding | 4.24e-01 | 1.00e+00 | 0.244 | 5 | 198 | 4124 |
GO:0005634 | nucleus | 4.38e-01 | 1.00e+00 | 0.267 | 4 | 158 | 3246 |
GO:0005887 | integral component of plasma membrane | 4.55e-01 | 1.00e+00 | 0.764 | 1 | 8 | 575 |
GO:0016021 | integral component of membrane | 4.79e-01 | 1.00e+00 | 0.356 | 2 | 19 | 1526 |
GO:0006355 | regulation of transcription, DNA-templated | 5.33e-01 | 1.00e+00 | 0.450 | 1 | 31 | 715 |
GO:0005886 | plasma membrane | 5.70e-01 | 1.00e+00 | 0.131 | 2 | 46 | 1784 |
GO:0005730 | nucleolus | 7.36e-01 | 1.00e+00 | -0.318 | 1 | 74 | 1217 |
GO:0070062 | extracellular vesicular exosome | 8.41e-01 | 1.00e+00 | -0.749 | 1 | 51 | 1641 |